{"id":"https://openalex.org/W4223997635","doi":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.103","title":"The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015\u20132020","display_name":"The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015\u20132020","publication_year":2022,"publication_date":"2022-04-15","ids":{"openalex":"https://openalex.org/W4223997635","doi":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.103"},"language":"en","primary_location":{"id":"doi:10.17749/2070-4909/farmakoekonomika.2022.103","doi":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.103","is_oa":true,"landing_page_url":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.103","pdf_url":"https://www.pharmacoeconomics.ru/jour/article/download/659/415","source":{"id":"https://openalex.org/S2764615430","display_name":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","issn_l":"2070-4909","issn":["2070-4909","2070-4933"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/I4210126206","host_organization_name":"Irbis (Czechia)","host_organization_lineage":["https://openalex.org/I4210126206"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.pharmacoeconomics.ru/jour/article/download/659/415","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007629094","display_name":"\u0418. \u041a. \u041f\u0435\u0442\u0440\u0443\u0445\u0438\u043d\u0430","orcid":"https://orcid.org/0000-0001-6207-5575","observed_orcids":["https://orcid.org/0000-0001-6207-5575"]},"institutions":[{"id":"https://openalex.org/I4210127240","display_name":"Samara State Medical University","ror":"https://ror.org/02z5czc07","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210127240"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"I. K. Petrukhina","raw_affiliation_strings":["Samara State Medical University"],"raw_orcid":"https://orcid.org/0000-0001-6207-5575","affiliations":[{"raw_affiliation_string":"Samara State Medical University","institution_ids":["https://openalex.org/I4210127240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038311789","display_name":"P. A. Lebedev","orcid":"https://orcid.org/0000-0003-3501-2354","observed_orcids":["https://orcid.org/0000-0003-3501-2354"]},"institutions":[{"id":"https://openalex.org/I4210127240","display_name":"Samara State Medical University","ror":"https://ror.org/02z5czc07","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210127240"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"P. A. Lebedev","raw_affiliation_strings":["Samara State Medical University"],"raw_orcid":"https://orcid.org/0000-0003-3501-2354","affiliations":[{"raw_affiliation_string":"Samara State Medical University","institution_ids":["https://openalex.org/I4210127240"]}]},{"author_position":"middle","author":{"id":null,"display_name":"E. P. Gladunova","orcid":"https://orcid.org/0000-0001-5198-0393","observed_orcids":["https://orcid.org/0000-0001-5198-0393"]},"institutions":[{"id":"https://openalex.org/I4210127240","display_name":"Samara State Medical University","ror":"https://ror.org/02z5czc07","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210127240"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"E. P. Gladunova","raw_affiliation_strings":["Samara State Medical University"],"raw_orcid":"https://orcid.org/0000-0001-5198-0393","affiliations":[{"raw_affiliation_string":"Samara State Medical University","institution_ids":["https://openalex.org/I4210127240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076193540","display_name":"Tat'yana Konstantinovna Ryazanova","orcid":"https://orcid.org/0000-0002-4581-8610","observed_orcids":["https://orcid.org/0000-0002-4581-8610"]},"institutions":[{"id":"https://openalex.org/I4210127240","display_name":"Samara State Medical University","ror":"https://ror.org/02z5czc07","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210127240"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"T. K. Ryazanova","raw_affiliation_strings":["Samara State Medical University"],"raw_orcid":"https://orcid.org/0000-0002-4581-8610","affiliations":[{"raw_affiliation_string":"Samara State Medical University","institution_ids":["https://openalex.org/I4210127240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076845872","display_name":"\u0410. \u0410. \u0413\u0430\u0440\u0430\u043d\u0438\u043d","orcid":"https://orcid.org/0000-0001-6665-1533","observed_orcids":["https://orcid.org/0000-0001-6665-1533"]},"institutions":[{"id":"https://openalex.org/I4210127240","display_name":"Samara State Medical University","ror":"https://ror.org/02z5czc07","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210127240"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. A. Garanin","raw_affiliation_strings":["Samara State Medical University"],"raw_orcid":"https://orcid.org/0000-0001-6665-1533","affiliations":[{"raw_affiliation_string":"Samara State Medical University","institution_ids":["https://openalex.org/I4210127240"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008911252","display_name":"Polina R. Blinkova","orcid":"https://orcid.org/0000-0002-8604-0729","observed_orcids":["https://orcid.org/0000-0002-8604-0729"]},"institutions":[{"id":"https://openalex.org/I4210127240","display_name":"Samara State Medical University","ror":"https://ror.org/02z5czc07","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210127240"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"P. R. Blinkova","raw_affiliation_strings":["Samara State Medical University"],"raw_orcid":"https://orcid.org/0000-0002-8604-0729","affiliations":[{"raw_affiliation_string":"Samara State Medical University","institution_ids":["https://openalex.org/I4210127240"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210127240"],"apc_list":{"value":15000,"currency":"RUB","value_usd":142},"apc_paid":{"value":15000,"currency":"RUB","value_usd":142},"fwci":0.1447,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.29401271,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"15","issue":"1","first_page":"59","last_page":"71"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14108","display_name":"Medical and Pharmaceutic Studies","score":0.7422000169754028,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T14108","display_name":"Medical and Pharmaceutic Studies","score":0.7422000169754028,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.17790000140666962,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.04100000113248825,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.9950000047683716},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9990000128746033},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.8379999995231628},{"id":"https://openalex.org/keywords/drug-use-trends","display_name":"drug use trends","score":0.6809999942779541},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9649999737739563},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9559999704360962},{"id":"https://openalex.org/keywords/diuretics","display_name":"diuretics","score":0.7599999904632568},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.8920000195503235},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.7889999747276306},{"id":"https://openalex.org/keywords/cardiovascular-disease-prevention","display_name":"cardiovascular disease prevention","score":0.7200000286102295},{"id":"https://openalex.org/keywords/samara-region","display_name":"Samara region","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C22723013","wikidata":"https://www.wikidata.org/wiki/Q475697","display_name":"Samara","level":2,"score":0.8227440118789673},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.6869070529937744},{"id":"https://openalex.org/C2780192228","wikidata":"https://www.wikidata.org/wiki/Q575890","display_name":"Antihypertensive drug","level":3,"score":0.6641215682029724},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6351406574249268},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5259922742843628},{"id":"https://openalex.org/C2910553456","wikidata":"https://www.wikidata.org/wiki/Q285044","display_name":"Angiotensin Receptor Blockers","level":4,"score":0.4839949607849121},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.4802318215370178},{"id":"https://openalex.org/C2776865356","wikidata":"https://www.wikidata.org/wiki/Q1182681","display_name":"Defined daily dose","level":3,"score":0.46143341064453125},{"id":"https://openalex.org/C30772137","wikidata":"https://www.wikidata.org/wiki/Q5164762","display_name":"Consumption (sociology)","level":2,"score":0.4342689514160156},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4298376441001892},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.35341036319732666},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3528352379798889},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.33026552200317383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3268855810165405},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.14697828888893127},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.17749/2070-4909/farmakoekonomika.2022.103","doi":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.103","is_oa":true,"landing_page_url":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.103","pdf_url":"https://www.pharmacoeconomics.ru/jour/article/download/659/415","source":{"id":"https://openalex.org/S2764615430","display_name":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","issn_l":"2070-4909","issn":["2070-4909","2070-4933"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/I4210126206","host_organization_name":"Irbis (Czechia)","host_organization_lineage":["https://openalex.org/I4210126206"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:0b25c7ddd4da4f9993f4eea156dde9ff","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/0b25c7ddd4da4f9993f4eea156dde9ff","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0424\u0430\u0440\u043c\u0430\u043a\u043e\u044d\u043a\u043e\u043d\u043e\u043c\u0438\u043a\u0430, Vol 15, Iss 1, Pp 59-71 (2022)","raw_type":"article"},{"id":"pmh:oai:oai.farmaec.elpub.ru:article/659","doi":null,"is_oa":true,"landing_page_url":"https://www.pharmacoeconomics.ru/jour/article/view/659","pdf_url":null,"source":{"id":"https://openalex.org/S4306401485","display_name":"PHARMACOECONOMICS (Eurasian Economic Community)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology; Vol 15, No 1 (2022); 59-71","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.17749/2070-4909/farmakoekonomika.2022.103","doi":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.103","is_oa":true,"landing_page_url":"https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.103","pdf_url":"https://www.pharmacoeconomics.ru/jour/article/download/659/415","source":{"id":"https://openalex.org/S2764615430","display_name":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","issn_l":"2070-4909","issn":["2070-4909","2070-4933"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/I4210126206","host_organization_name":"Irbis (Czechia)","host_organization_lineage":["https://openalex.org/I4210126206"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4223997635.pdf","grobid_xml":"https://content.openalex.org/works/W4223997635.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W2157677292","https://openalex.org/W2342209858","https://openalex.org/W2470755925","https://openalex.org/W2614578122","https://openalex.org/W2803009978","https://openalex.org/W2890481236","https://openalex.org/W2906906139","https://openalex.org/W3088294108","https://openalex.org/W4211019091"],"related_works":["https://openalex.org/W4413018924","https://openalex.org/W4312116183","https://openalex.org/W4394723175","https://openalex.org/W4327647621","https://openalex.org/W4413641497","https://openalex.org/W4319261089","https://openalex.org/W2093997951","https://openalex.org/W2079270749","https://openalex.org/W3047512009","https://openalex.org/W2347878540"],"abstract_inverted_index":{"Objective:":[0],"to":[1],"determine":[2],"the":[3,10,21,36,40,44,61,74,81,85,97,136,178,183,191,202,232,236,246],"compliance":[4],"of":[5,12,20,24,39,43,54,65,80,84,91,102,141,171,173,182,193,201,208,219,225,231,235,248],"antihypertensive":[6,25,116],"drugs":[7,117,176,195,251],"consumption":[8,22,192,218,247],"with":[9,206,216,241],"trends":[11],"modern":[13,250],"pharmacotherapy.":[14],"Material":[15],"and":[16,63,70,100,112,130,149,161,166,196,213,252],"methods.":[17],"The":[18,52,88,114,169,229],"analysis":[19,93,170],"level":[23],"drugs,":[26],"their":[27,131,253],"fixed":[28],"combinations":[29],"(FC),":[30],"as":[31,33,153],"well":[32],"statins":[34,197,226],"in":[35,47,68,78,105,163,177,186,245],"retail":[37,82],"sector":[38],"pharmaceutical":[41,237],"market":[42,238],"Samara":[45,86,184],"Region":[46,185],"2015\u20132020":[48],"was":[49,58],"carried":[50],"out.":[51],"material":[53],"this":[55],"retrospective":[56],"study":[57],"information":[59],"about":[60],"nomenclature":[62],"volume":[64],"drug":[66,103],"sales":[67,172,224],"physical":[69],"monetary":[71],"terms":[72],"for":[73,110,135,157],"period":[75],"under":[76],"review":[77],"one":[79],"pharmacies":[83],"Region.":[87],"traditional":[89],"method":[90],"pharmacoepidemiological":[92],"aimed":[94,143],"at":[95,144],"studying":[96],"correctness,":[98],"completeness":[99],"preferences":[101],"use":[104,140],"real":[106],"practice":[107],"is":[108,151,239],"questionnaires":[109],"physicians":[111],"patients.":[113],"main":[115],"(diuretics,":[118],"angiotensin-converting":[119,209],"enzyme":[120,210],"inhibitors,":[121],"angiotensin":[122],"II":[123],"receptor":[124],"blockers,":[125,128],"calcium":[126],"channel":[127],"\u03b2-blockers)":[129],"FC":[132,220],"were":[133],"selected":[134],"analysis.":[137],"Results.":[138],"Long-term":[139],"medications":[142],"reducing":[145,158],"high":[146],"blood":[147],"pressure":[148],"hypercholesterolemia":[150],"seen":[152],"an":[154],"effective":[155,249],"strategy":[156],"cardiovascular":[159],"complications":[160],"mortality":[162],"both":[164],"primary":[165],"secondary":[167],"prevention.":[168],"basic":[174],"cardiological":[175],"pharmacy":[179],"network":[180],"segment":[181,234],"5-year":[187],"dynamics":[188,244],"showed":[189],"that":[190],"hypotensive":[194],"makes":[198],"up":[199],"4.72%":[200],"total":[203],"item":[204],"sales,":[205],"prevalence":[207],"inhibitors":[211],"(28.0%)":[212],"\u03b2-blockers":[214],"(23.5%),":[215],"insufficient":[217,242],"(23.7%),":[221],"extremely":[222],"low":[223],"(7.58%).":[227],"Conclusion.":[228],"structure":[230],"studied":[233],"conservative":[240],"positive":[243],"FC.":[254]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-07T09:51:55.459714","created_date":"2022-04-19T00:00:00"}